Spotlight On... Study: Minimally invasive bead embolization effective at inducing weight loss; St. Jude launches aortic heart valve replacement valve in EU; Alere to stay put in P&G consumer Dx joint venture; and more...

@FierceMedDev: Illumina expands San Diego HQ with new Blackrock-owned digs starting mid-2017. Story | Follow @FierceMedDev

@EmilyWFierce: Gilead keeps Martin's pay going strong at $18.8M in his last year as CEO. More | Follow @EmilyWFierce

> St. Jude Medical ($STJ) has launched its Trifecta valve with Glide Technology in Europe; it's for the replacement of diseased, damaged or malfunctioning aortic heart valves. It's for use in minimally invasive and conventional surgical procedures. More

> Alere ($ALR) no longer plans to divest its stake in its consumer diagnostics joint venture with Proctor & Gamble that was formed in 2007, Swiss Precision Diagnostics. Reuters

> The Robert Wood Johnson Foundation is funding a $500,000 competition for Apple ResearchKit-based studies that address mood and its role in daily life. More

Biotech News

@FierceBiotech: $BIND Therapeutics looks for immuno-oncology partner, CEO tells FierceBiotech he may have to sell the company. Story | Follow @FierceBiotech

@JohnCFierce: A capricious bureaucracy taking something away is irritating. Treasury targeting a megainversion is predictable. | Follow @JohnCFierce

> Heat Biologics to slash staff by a fifth, cut more than half of patients in cancer trial. Story

> Roche steps in to help fund $34M Lumos round for rare disease R&D. More

Pharma News

@FiercePharma: Tokyo-listed SanBio gets Japan PMDA nod for brain trauma stem cell trial. Article | Follow @FiercePharma

@EricPFierce: Unable to find a buyer, Sun will close the Ranbaxy plant in Ireland, lay off 70 remaining workers. Story | Follow @EricPFierce

@CarlyHFierce: Facing a new assessment of Kyprolis, Amgen castigates cost-effectiveness team's methods. More | Follow @CarlyHFierce

> Lilly CEO Lechleiter nabs $16.6M in 2015 pay, with hefty boosts to incentive compensation. News

> Shire promises Treasury rules won't nix its deal for U.S.-based Baxalta. Article

Pharma Asia News

> China biotech Essex Bio signs $3.5M antibodies deal with U.S. antibody specialist Abpro. Item

> Tokyo-listed SanBio gets Japan PMDA nod for brain trauma stem cell trial. Article

> Eisai to work with Russia's PharmStandard on oncology manufacture. News

> Lupin's new M&A deals to strike at Indian rival Sun's perch in Japan. More

> Drug price cuts in Japan sink in though details sparse. Story

CRO News

> Failure of Pfizer-Allergan deal may hit CROs long term. More

> QPS expands biologics service with SCIEX deal. Article

> InVentiv to go public, hopes to raise $500M. Story

> GE Healthcare rolls out new R&D partnership in Turkey. News

> SynteractHCR sends team to the American Lung Association's 'Fight for Air Climb.' More

Pharma Manufacturing News

> Pfizer recalls mislabeled bottles of adult Robitussin. More

> Eisai turns to PharmStandard for manufacturing in Russia. Article

> New player jumping into cell therapies manufacturing. Story

> Teva expands API site in Hungary. News

> Pfizer to look for 20% cost cuts in some manufacturing, Ireland employees told. Report

Suggested Articles

BD will begin offering a point-of-care COVID-19 antibody assay, which operates like a combination of a blood glucose test and a home pregnancy test.

Smith+Nephew is contracting with the U.K. government to build a new ventilator specifically designed for large-scale production.

NantWorks’ ImmunityBio has begun a supercomputing collaboration with Microsoft to map out the spike protein of the novel coronavirus.